OUR FOUNDATIONS
Overview
The ELMA Foundation
The ELMA Relief Foundation
The ELMA Growth Foundation
The ELMA Music Foundation
The ELMA Vaccines & Immunization Foundation
The ELMA South Africa Foundation
The ELMA Caribbean Foundation
The ELMA Climate Foundation
OUR INVESTMENTS
Explore by Foundation
Explore by Geography
NEWS & STORIES
News & Stories
ABOUT US
About Us
Progress Reports
Our Investment Frameworks
Evidence & Learning

ELMA Philanthropies

OUR FOUNDATIONS
Overview
The ELMA Foundation
The ELMA Relief Foundation
The ELMA Growth Foundation
The ELMA Music Foundation
The ELMA Vaccines & Immunization Foundation
The ELMA South Africa Foundation
The ELMA Caribbean Foundation
The ELMA Climate Foundation
OUR INVESTMENTS
Explore by Foundation
Explore by Geography
NEWS & STORIES
News & Stories
ABOUT US
About Us
Progress Reports
Our Investment Frameworks
Evidence & Learning
CureVac
August 17, 2017
Private Sector Solutions
The ELMA Foundation
CureVac
The ELMA Foundation
August 17, 2017
Private Sector Solutions

CureVac

The ELMA Foundation
August 17, 2017
Private Sector Solutions
CureVac.png
 

CureVac


Homepage >

Donate >


INVESTMENT SYNOPSIS

Investment in a biotechnology company that focuses on using messenger RNA to develop new therapeutics and vaccines

FOUNDATION

The ELMA Foundation

FOCUS AREA

Private Sector Solutions

REGION

Africa


Tagged: Africa, Impact Investments

Newer PostCo-Impact
Older PostDelta Philanthropies

Explore The ELMA Group of Foundations

Full-ELMA.png
Full-Relief.png
Full-Growth.png
Full-Music.png
Vaccines%2BFix.jpg
South-Africa.png
6. Footer Banner box.jpg
Foundation Squares_Climate.jpg
Back to Top
Logo-Footer.png
 
 

• About Us • Investments • News • Careers • Privacy Policy •
© 2018, The ELMA Philanthropies Services (U.S.) Inc.

 
instagram
Linkedin